Signals from lymphocytes in colon cancer.

Por Kiessling, R
Publicado em 1997

Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation

Por Kono, K, Mimura, K, Kiessling, R
Publicado em 2013

Mechanisms of lymphocytic choriomeningitis virus-induced hemopoietic dysfunction.

Por Thomsen, A R, Pisa, P, Bro-Jørgensen, K, Kiessling, R
Publicado em 1986

Immune reactivity to fractionated Leishmania aethiopica antigens during active human infection.

Por Laskay, T, Mariam, H G, Berhane, T Y, Fehniger, T E, Kiessling, R
Publicado em 1991

“Anomalous” THY-1(+) killer cells in allogeneic and F1-anti-parental mixed leukocyte culture. Relation to natural killer cells and allospecific cytotoxic T lymphocytes

Por Karre, K, Seeley, JK, Eriksson, E, Burton, RC, Kiessling, R
Publicado em 1982

Induction of heat shock protein 60 expression in human monocytic cell lines infected with Mycobacterium leprae.

Por Beimnet, K, Söderström, K, Jindal, S, Grönberg, A, Frommel, D, Kiessling, R
Publicado em 1996

Interferon gamma induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens.

Por Taniguchi, K, Petersson, M, Höglund, P, Kiessling, R, Klein, G, Kärre, K
Publicado em 1987

Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer

Por Miyan, M., Schmidt-Mende, J., Kiessling, R., Poschke, I., de Boniface, J.
Publicado no J Transl Med (2016)

Target-effector cell interaction in the natural killer cell system. V. Energy requirements, membrane integrity, and the possible involvement of lysosomal enzymes.

Por Roder, J C, Argov, S, Klein, M, Petersson, C, Kiessling, R, Andersson, K, Hansson, M
Publicado em 1980

Analysis of gamma delta V region usage in normal and diseased human intestinal biopsies and peripheral blood by polymerase chain reaction (PCR) and flow cytometry.

Por Bucht, A, Söderström, K, Esin, S, Grunewald, J, Hagelberg, S, Magnusson, I, Wigzell, H, Grönberg, A, Kiessling, R
Publicado em 1995

Cripto-1 vaccination elicits protective immunity against metastatic melanoma

Por Ligtenberg, M. A., Witt, K., Galvez-Cancino, F., Sette, A., Lundqvist, A., Lladser, A., Kiessling, R.
Publicado no Oncoimmunology (2016)

Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies.

Por Pisa, P, Halapi, E, Pisa, E K, Gerdin, E, Hising, C, Bucht, A, Gerdin, B, Kiessling, R
Publicado em 1992

Specific lysis of mycobacterial antigen-bearing macrophages by class II MHC-restricted polyclonal T cell lines in healthy donors or patients with tuberculosis.

Por Kumararatne, D S, Pithie, A S, Drysdale, P, Gaston, J S, Kiessling, R, Iles, P B, Ellis, C J, Innes, J, Wise, R
Publicado em 1990

Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker

Por Salazar-Onfray, F, López, M, Lundqvist, A, Aguirre, A, Escobar, A, Serrano, A, Korenblit, C, Petersson, M, Chhajlani, V, Larsson, O, Kiessling, R
Publicado em 2002

A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer

Por Pavlenko, M, Roos, A-K, Lundqvist, A, Palmborg, A, Miller, A M, Ozenci, V, Bergman, B, Egevad, L, Hellström, M, Kiessling, R, Masucci, G, Wersäll, P, Nilsson, S, Pisa, P
Publicado em 2004